A Cochrane review of 12 trials showed that information regarding the effects of chlorhexidine applied to the umbilical cords of newborns in hospital settings on neonatal mortality is not clear.[10] Two trials had moderate-quality evidence that chlorhexidine cord cleansing reduced the risk of omphalitis/infections compared with dry cord care. Another two trials had low-quality evidence that no difference exists for omphalitis/infections between groups receiving chlorhexidine skin cleansing and dry cord care. However, there was high-quality evidence that chlorhexidine skin or cord care in the community setting led to a 50% reduction in the incidence of omphalitis and a 12% reduction in neonatal mortality.[10] No difference was noted for neonatal mortality or the risk of infections in hospital settings for maternal vaginal chlorhexidine use compared to usual care.